Research on new and better ways to treat cancer. Covers radiotherapy, targeted microdroplets, nerve-injury protection, drug combinations, and tumor models.
Researchers identified a novel mutation in the KIT gene that contributes to crizotinib resistance in ROS1+ non-small cell lung cancer patients. Ponatinib, a KIT tyrosine kinase inhibitor, demonstrates potential as a therapeutic option for overcoming this resistance.
Researchers have developed a magnetically controlled material composed of enzymes entrapped within magnetite particles, enabling targeted treatment of cancer and thrombosis. The new material stabilizes itself without additional stabilizers, making it suitable for intravenous injection.
A review found Gamblers Anonymous reduces depression, anxiety, and stress in individuals using it in conjunction with other therapeutic approaches. Combining GA with stress management or cognitive behavioral therapy shows significant improvements in gambling symptoms and overall well-being.
Researchers at University of California, San Diego School of Medicine found that certain groups of gastrointestinal stromal tumors result in a much higher mortality rate than expected. The study analyzed data from 378 patients with malignant GISTs and discovered significant variability in size and malignant behavior.
Women who underwent uterine fibroid embolization reported improved sexual function, including pain, desire, arousal, and satisfaction. About nine in 10 women also experienced a better overall quality of life, with average scores increasing from 45 to 71 one year after treatment.
The Society of Interventional Radiology honored two research papers for their impact on patient care. Dong Il Gwon's study validated a rapid PARTO procedure for treating gastric varices, while Ron C. Gaba's research explored gene expression in hepatocellular carcinoma for improved treatment outcomes.
A recent study published by The Endocrine Society found that radioactive iodine treatment can impair a woman's remaining egg supply, known as ovarian reserve. Women who received high doses of radiation had significantly lower levels of anti-Müllerian hormone (AMH) after treatment.
Scientists at EMBL have increased the efficiency of gene therapy tool Sleeping Beauty, which is being trialed for therapies targeting B-cell leukaemias and lymphomas. The enhancement results in a 30% increase in efficiency and aims to improve patient outcomes.
A study by NIH researchers found that children with Cushing syndrome are at higher risk for depression, anxiety and suicidal thoughts months after successful treatment. The researchers screened the case histories of 149 patients and found 9 children had thoughts of suicide.
A recent U.S. Preventive Services Task Force recommendation suggests pairing smoking cessation with lung cancer screening to maximize benefits and reduce risk. This guideline aims to provide tobacco treatment in conjunction with lung screening to encourage smokers to quit.
Researchers at Beth Israel Deaconess Medical Center have identified a 5-gene classifier that can accurately detect early stages of pancreatic cancer, offering hope for earlier diagnosis and treatment. The classifier achieved high sensitivity and specificity rates in training and validation datasets.
A large study from Japan found that cancer patients who died at home tended to live longer than those who died in hospitals. The study suggests that oncologists should not hesitate to refer patients for home-based palliative care. Home death may have a positive influence on survival, contrary to previous concerns.
Case Western Reserve University scientists develop an optical sensor using nanostructured metamaterials, enabling detection of single lightweight molecules in dilute solutions. The device has been shown to be 1 million times more sensitive than current methods, with potential applications for early cancer diagnosis and treatment.
Researchers at Loyola University Health System have developed a new approach to treating hepatitis C, using mathematical models to predict when patients can safely stop taking direct-acting antiviral medication. This approach could lead to a 50% reduction in treatment cost and improved patient adherence.
Researchers found a compound that prevents scarring in the lungs and liver also shows promise in preventing pancreatic fibrosis. The study used an animal model to demonstrate the effectiveness of the integrin inhibitor in halting fibrosis and potentially preserving pancreatic function.
Researchers found that truckers with OSA who didn't adhere to treatment had a five-fold increase in preventable crashes compared to healthy drivers. Regular screening and treatment can reduce large truck accidents, deaths, and injuries.
A study of 146 veterans with life-threatening illnesses found that exploring their values can help set effective goals for healthcare and treatment plans. The researchers identified five key themes: self-sufficiency, life enjoyment, connectedness and legacy, balancing quality and length of life, and engagement in care.
A new study provides insight into the role of RNA editing in cancer, identifying over 2,000 genes with significant changes in RNA editing levels between tumor and normal tissues. Researchers found that these changes may be linked to different clinical outcomes.
Researchers have developed a CRISPR-Cas9 based method to track the movement of RNA in living cells. This approach enables the study of disease-related RNA processes and may support therapeutic approaches to correct disease-causing RNA behaviors.
A clinical study found that veterans with subclinical PTSD experience a 29% drop in symptoms after treatment, compared to 14% for those with full PTSD. This discovery highlights the potential benefits of early-stage PTSD treatment and could lead to cost-effectiveness in treating this common disorder.
LDNscience.org offers comprehensive information on low dose naltrexone (LDN) for patients with autoimmune diseases and chronic conditions. The revamped website provides resources, research, and educational materials to support treatment and quality of life.
Researchers review phosphonate-based matrix metalloproteinase inhibitors, which exhibit selective and potent activity on bone resorption. The authors propose these alternatives as a potential therapeutic target for chronic inflammation and cancer.
Scientists have developed a new imaging technique that can detect diseases earlier with enhanced sensitivity, allowing for earlier diagnosis and treatment. The technique uses probes that light up specific targets inside cells, enabling researchers to track changes in molecular make-up of tissues.
Adults aged 55-74 with a history of current or former smoking and 30+ pack-years are advised to undergo annual low-dose CT scans up to three times. This guideline aims to detect lung cancer at an early stage, reducing serious illness and death. Screening should be conducted in healthcare settings with expertise in diagnosing lung cancer.
A study published in the EMBO Journal has identified a gene candidate, GEMC1, associated with a subtype of ciliopathy. GEMC1 regulates key genes involved in this disease, suggesting its potential as a therapeutic target for rare diseases affecting 5 in 10,000 people or fewer.
Researchers discovered novel genetic variants in a hormone receptor-positive male breast cancer patient, which led to a prolonged stable disease. The study provides new insights into the genomic landscape of male breast cancer and suggests potential benefits of combining treatments to block the PI3K/Akt/mTOR pathway.
Research reveals depression alters oxidative stress levels, leading to increased risk of cardiovascular disease and cancer. Treatment can improve malondialdehyde levels, while zinc and uric acid levels normalize.
Men with low-grade prostate cancer are increasingly opting for active surveillance, a management strategy that monitors the cancer's progression without immediate treatment. The study found that about 59% of patients managed by active surveillance remained on this approach after five years.
A pooled analysis of 13 studies covering 33,571 subjects found a significant association between pre-labor cesarean delivery and an increased risk of acute lymphoblastic leukemia in children. The study suggests that the stress response in the fetus caused by labor may be involved in this correlation.
Research breakthrough reveals pancreatic tumours often lose miR-137 expression, triggering uncontrolled cell growth and cancer. Restoring normal miR-137 levels induces senescence and stops cells from spreading.
The Helmholtz Zentrum Munchen has been awarded 14 ERC grants, with three scientists receiving 6 million euros. Dr. Daniel Razansky is investigating non-invasive brain imaging methods, while Dr. Irmela Jeremias focuses on targeted tumor treatment and Dr. Mathias Heikenwaelder explores immune system interactions in liver disease.
The American Cancer Society report reveals progress in reducing cancer death rates among African-Americans, but racial disparities persist in breast and colorectal cancers. The study finds that disparities in access to care and screening contribute to these disparities.
Higher body weight and taller stature during adolescence may increase the risk of developing Non-Hodgkin's Lymphoma later in life. A study of 2,352,988 teens found a 25% increased risk of NHL associated with adolescent overweight and obesity.
Researchers at the University of Minnesota have made a breakthrough in understanding how retrovirus RSV brings together protein molecules to form tiny molecular claws, which can help develop anti-retrovirals to target integrase functions and improve HIV/AIDS therapies.
A recent discovery by FAU researchers reveals a mechanism that promotes metastasis and resistance to treatment in aggressive cancer types. They identified a gene set associated with particularly bad prognosis in breast cancer, enabling the development of biological markers for aggressive tumours.
Researchers at MD Anderson Cancer Center proposed a new staging system for HPV-related oropharyngeal cancer, which better separates patients with different survival rates. The new groupings were proven to have greater predictive power than the current system, particularly in identifying stage III disease with a high risk of death.
Researchers at Trinity College Dublin have made a significant discovery in how our immune system responds to TB, enabling the development of more effective vaccines and personalized therapies. The study highlights the importance of the protein Mal in cell signaling and its impact on responses to Interferon Gamma.
According to a Norwegian study of male cancer patients diagnosed under the age of 25, many male cancer patients have problems reproducing. The researchers found that male cancer survivors are three times as likely to turn to assisted fertilization to have children as males with no cancer diagnosis.
A national patient-powered registry, MyLymeData, has enrolled over 3,000 patients to accelerate research for chronic Lyme disease. Big data tools can help identify treatment responses and subgroup analysis, leading to a better understanding of the disease.
Researchers analyze 500 scientific articles to develop a mathematical model for muscle-invasive bladder cancer. They identify potential biomarkers and clinical parameters to accurately determine cancer stage and develop individual treatment strategies.
Researchers at Tufts University have discovered the bioelectric mechanism behind craniofacial defects in Andersen-Tawil syndrome, a rare genetic disorder. The finding may also shed light on fetal alcohol syndrome and other conditions.
A new analysis found that both phone-based and web-based tobacco cessation programs can help individuals quit smoking. However, certain personal characteristics, such as age, race, ethnicity, education level, and employment status, may influence program effectiveness, with Web-based programs being slightly more successful for some groups.
A Yale study applying evolutionary biology tools sheds light on cancer's genetic origins and tumor progression. The research mapped genetic mutations in normal, primary, and metastatic tumor tissue, revealing that metastases originate from different paths within primary tumors and can diverge early in cancer history.
A new DNA-based digital PCR assay has been developed to detect persistent disease in CML patients who appear to be in remission. The assay was found to be more sensitive than current methods, detecting disease in 81% of samples, and may lead to improved treatment decisions for individual patients.
Scientists discovered that PAD4 works with BRD4 to switch E2F-1 from promoting cell growth to inducing inflammation in cancers. Inhibiting both proteins reduced arthritis symptoms and decreased inflammatory products in mice.
A special issue of Pediatric Blood & Cancer establishes evidence-based standards for pediatric psychosocial care, addressing topics like monitoring psychosocial health and supporting siblings. The standards aim to improve quality of life outcomes for children with cancer and their family members.
Researchers at Michigan Medicine have identified a strong interaction between KRAS and AGO2 that could contribute to its role in cancer development. The study suggests that targeting this interaction may be a potential therapy for KRAS-related cancers.
A 28-year-old transgender woman experienced a delay in testicular cancer diagnosis due to inadequate access to insurance coverage and transportation challenges. The case study emphasizes the importance of addressing biopsychosocial needs and creating venues for medical providers to learn appropriate care for transgender patients.
Researchers at CNIO have identified two biomarkers, p21 and mTOR activation, that predict a less aggressive head and neck cancer progression. The study's findings could lead to personalized treatment options for patients.
Researchers discovered a new way to classify gliomas by analyzing their molecular characteristics, specifically DNA methylation levels. This approach predicts which tumors are more likely to grow rapidly and can guide treatment decisions.
A collection of articles explores fertility issues in patients with cancer, including the legal framework and potential solutions for disputes involving donated genetic material. The articles also highlight the importance of oncologists providing fertility care to their patients.
Researchers discovered a new biomarker, pro-NPY, which correlates with increased risk of prostate cancer death. The study suggests that high pro-NPY levels can predict prostate cancer-related death among diagnosed patients who haven't received surgical treatment.
A study by Mayo Clinic researchers found that people who quit smoking for over 15 years are still at a higher risk of developing lung cancer. Expanding lung cancer screening to include this group could detect more cases and further reduce mortality.
Researchers at Scripps Research Institute and UC Berkeley have made a breakthrough in understanding the proteasome, a molecular machine responsible for breaking down toxic proteins. The new study reveals how a crucial enzyme, Rpn11, is activated to remove harmful proteins from cells, providing potential new therapies for diseases such ...
A recent study published in Nature Genetics has identified 10 new genes linked to lupus, an autoimmune disease affecting millions worldwide. The research analyzed over 17,000 DNA samples from Asian populations and found that these genes play a significant role in the development of lupus.
New figures show that screening picks up the majority of bowel cancer cases at an early stage. Screening detected more than a third of bowel cancers at stage one and fewer than one in ten advanced to stage four. Patients whose cancers are picked up at an earlier stage have better chances of survival due to effective treatment.
Researchers at the University of Colorado Boulder have developed light-activated therapeutic nanoparticles that successfully killed 92% of drug-resistant bacterial cells in a lab-grown culture. The quantum dots, which can be tailored to specific infections, offer a new hope for combating antibiotic-resistant superbugs.
A large-scale study by the University of Melbourne found that both real and sham acupuncture showed a 40% improvement in hot flush severity and frequency after eight weeks. The benefits were sustained at six months. Women with breast cancer or ovarian removal were not included.
The UK's first national tissue bank aims to develop new treatments and improve patient outcomes for pancreatic cancer. The Tissue Bank will store high-quality samples from consenting patients, enabling researchers to test ideas and validate their research more effectively.
Researchers at Cornell University have discovered potent cancer-killing proteins that can travel by white blood cells to kill tumors in the bloodstream of mice with metastatic prostate cancer. The therapy has shown several advantages, including no toxicity and good results with low dosages.